A woman tells the BBC about her anxieties after a US-funded clinic that gave her medication closed.

The Global Fund has secured access to lenacapavir, a groundbreaking HIV prevention drug, for low and middle-income countries, marking a significant step in combating the HIV epidemic, especially among ...

Re: "20-baht flat rate fare gets the nod", (BP, July 9). The cabinet yesterday approved a flat-rate fare of 20 baht for all ...

AIDS Healthcare Foundation (AHF) denounces Gilead Sciences for once again excluding Latin America and the Caribbean (LAC) from affordable access to a groundbreaking HIV prevention drug, lenacapavir.

Gilead Sciences (NasdaqGS:GILD) recently announced a partnership with the Global Fund to supply lenacapavir for HIV ...

Gilead will supply lenacapavir to Global Fund countries for HIV prevention, but questions remain amid PEPFAR cuts and funding ...

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...

The Bill and Melinda Gates Foundation and the Wellcome Trust have pledged R100 000 000.00 each. They put a condition – that each R100 million they contribute be matched by R200 million from our own ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalised plans to ...

US antivirals specialist Gilead Sciences today announced a strategic partnership agreement with the Global Fund to Fight AIDS ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...